Literature DB >> 12241867

Dilated cardiomyopathy: a genetically heterogeneous disease.

Tony Shaw1, Perry Elliott, William J McKenna.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12241867     DOI： 10.1016/S0140-6736(02)09879-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  [Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].

Authors:  Sabine Pankuweit; Anette Richter; Volker Ruppert; Bernhard Maisch
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

Review 2.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 3.  Insights into human beta-cardiac myosin function from single molecule and single cell studies.

Authors:  Sivaraj Sivaramakrishnan; Euan Ashley; Leslie Leinwand; James A Spudich
Journal:  J Cardiovasc Transl Res       Date:  2009-09-29       Impact factor: 4.132

Review 4.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 5.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 6.  [Classification, genetic predisposition and risk factors for the development of cardiomyopathies].

Authors:  S Pankuweit; A Richter; V Ruppert; R Funck; B Maisch
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

Review 7.  Overview of inherited metabolic disorders causing cardiovascular disease.

Authors:  D E L Wilcken
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  [Familial predisposition and microbial etiology in dilated cardiomyopathy].

Authors:  Sabine Pankuweit; Anette Richter; Volker Ruppert; Bernhard Maisch
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

9.  Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy.

Authors:  Comlan Missihoun; David Zisa; Arsalan Shabbir; Huey Lin; Techung Lee
Journal:  Mol Cell Biochem       Date:  2008-08-26       Impact factor: 3.396

10.  Non-compaction of ventricular myocardium with polycystic kidney disease with cardiogenic cerebral embolism.

Authors:  Monu Rani; Rajesh Rajput; Sanat Mishra; Rakesh Garg
Journal:  BMJ Case Rep       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.